Vitamin E is essential for Purkinje neuron integrity

Neuroscience

Volumn 260, Issue , 2014, Pages 120-129

  Ulatowski, L ^a   Parker, R ^b   Warrier, G ^c   Sultana, R ^c   Butterfield, D A ^c   Manor, D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Ataxia; Cerebellum; Oxidative stress; Purkinje neuron; Tocopherol; Vitamin E

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL TRANSFER PROTEIN; CARRIER PROTEIN; ISOPROSTANE DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ALPHA TOCOPHEROL DEFICIENCY; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CELL SIZE; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBELLUM; CEREBELLUM CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FEMALE; LIMIT OF QUANTITATION; MALE; MOTOR DYSFUNCTION; MOUSE; NERVE FIBER GROWTH; NERVOUS SYSTEM PARAMETERS; NEUROLOGIC DISEASE; NEURON INTEGRITY; NEUROPROTECTION; NITROSYLATION; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PERIKARYON; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN NITROSYLATION; PURKINJE CELL;

3-NITROTYROSINE; 3-NT; AD; ALZHEIMER'S DISEASE; ANALYSIS OF VARIANCE; ANOVA; ATAXIA; ATAXIA WITH VITAMIN E DEFICIENCY; AVED; CEREBELLUM; CONDITIONED STIMULUS; CS; NIEMANN PICK DISEASE TYPE C; NPC; OXIDATIVE STRESS; PURKINJE NEURON; SCA; SPINOCEREBELLAR ATAXIA; T-HODE; TBARS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TOCOPHEROL; TOTAL HYDROXYOCTADECADIENOIC ACID; TTP; TTPA; UNCONDITIONED STIMULUS; US; VITAMIN E; Α-TOCOPHEROL TRANSFER PROTEIN; Α-TOCOPHEROL TRANSFER PROTEIN GENE FOR THE HUMAN VERSION; Α-TOCOPHEROL TRANSFER PROTEIN GENE FOR THE MURINE VERSION;

ALPHA-TOCOPHEROL; ANIMALS; CARRIER PROTEINS; CEREBELLUM; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; OXIDATIVE STRESS; PREFRONTAL CORTEX; PURKINJE CELLS; TYROSINE; VITAMIN E DEFICIENCY;

EID: 84892450811     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.12.001     Document Type: Article

References (84)

1. Aleman M. Miscellaneous neurologic or neuromuscular disorders in horses. Vet Clin North Am Equine Pract 2011, 27:481-506.
2. Altman J. Postnatal development of the cerebellar cortex in the rat. II. Phases in the maturation of Purkinje cells and of the molecular layer. J Comp Neurol 1972, 145:399-463.
3. Amiel J., Maziere J.C., Beucler I., Koenig M., Reutenauer L., Loux N., Bonnefont D., Feo C., Landrieu P. Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up. J Inherit Metab Dis 1995, 18:333-340.
4. Buccafusco J.J. Methods of behavior analysis in neuroscience 2001, CRC Press, Boca Raton.
5. Buhmann C., Arlt S., Kontush A., Moller-Bertram T., Sperber S., Oechsner M., Stuerenburg H.J., Beisiegel U. Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiol Dis 2004, 15:160-170.
6. Burton G.W., Traber M.G. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990, 10:357-382.
7. Burton G.W., Cheeseman K.H., Doba T., Ingold K.U., Slater T.F. Vitamin E as an antioxidant in vitro and in vivo. Ciba Found Symp 1983, 101:4-18.
8. Butterfield D.A., Reed T., Sultana R. Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radic Res 2011, 45:59-72.
9. Cavalier L., Ouahchi K., Kayden H.J., Di Donato S., Reutenauer L., Mandel J.L., Koenig M. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 1998, 62:301-310.
10. Chen P., Peng C., Luff J., Spring K., Watters D., Bottle S., Furuya S., Lavin M.F. Oxidative stress is responsible for deficient survival and dendritogenesis in Purkinje neurons from ataxia-telangiectasia mutated mutant mice. J Neurosci 2003, 23:11453-11460.
11. Cuddihy S.L., Ali S.S., Musiek E.S., Lucero J., Kopp S.J., Morrow J.D., Dugan L.L. Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in the brain. J Biol Chem 2008, 283:6915-6924.
12. Dinning J.S., Day P.L. Vitamin E deficiency in the monkey. I. Muscular dystrophy, hematologic changes, and the excretion of urinary nitrogenous constituents. J Exp Med 1957, 105:395-402.
13. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 1957, 46:208-209.
14. Eccles J.C., Llinas R., Sasaki K. The excitatory synaptic action of climbing fibres on the Purkinje cells of the cerebellum. J Physiol 1966, 182:268-296.
15. Eccles J.C., Llinas R., Sasaki K. The inhibitory interneurones within the cerebellar cortex. Exp Brain Res 1966, 1:1-16.
16. Eccles J.C., Llinas R., Sasaki K. Intracellularly recorded responses of the cerebellar Purkinje cells. Exp Brain Res 1966, 1:161-183.
17. Eccles J.C., Llinas R., Sasaki K. The mossy fibre-granule cell relay of the cerebellum and its inhibitory control by Golgi cells. Exp Brain Res 1966, 1:82-101.
18. Eccles J.C., Llinas R., Sasaki K. Parallel fibre stimulation and the responses induced thereby in the Purkinje cells of the cerebellum. Exp Brain Res 1966, 1:17-39.
19. Einarson L. Deposits of fluorescent acid-fast products in the nervous system and skeletal muscles of adult rats with chronic vitamin-E deficiency. J Neurol Neurosurg Psychiatry 1953, 16:98-109.
20. Enrione E.B., Weeks O.I., Kranz S., Shen J. A vitamin E-deficient diet affects nerve regeneration in rats. Nutrition 1999, 15:140-144.
21. Ford E.S., Sowell A. Serum alpha-tocopherol status in the United States population: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999, 150:290-300.
22. Ford E.S., Schleicher R.L., Mokdad A.H., Ajani U.A., Liu S. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr 2006, 84:375-383.
23. Fulgoni V.L., Keast D.R., Auestad N., Quann E.E. Nutrients from dairy foods are difficult to replace in diets of Americans: food pattern modeling and an analyses of the National Health and Nutrition Examination Survey 2003-2006. Nutr Res 2011, 31:759-765.
24. Fulgoni V.L., Keast D.R., Bailey R.L., Dwyer J. Foods, fortificants, and supplements: Where do Americans get their nutrientsα. J Nutr 2011, 141:1847-1854.
25. Gatti R.A., Vinters H.V. Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser 1985, 19:225-232.
26. Geller A., Gilles F., Shwachman H. Degeneration of fasciculus gracilis in cystic fibrosis. Neurology 1977, 27:185-187.
27. Gohil K., Godzdanker R., O'Roark E., Schock B.C., Kaini R.R., Packer L., Cross C.E., Traber M.G. Alpha-tocopherol transfer protein deficiency in mice causes multi-organ deregulation of gene networks and behavioral deficits with age. Ann N Y Acad Sci 2004, 1031:109-126.
28. Gohil K., Oommen S., Quach H.T., Vasu V.T., Aung H.H., Schock B., Cross C.E., Vatassery G.T. Mice lacking alpha-tocopherol transfer protein gene have severe alpha-tocopherol deficiency in multiple regions of the central nervous system. Brain Res 2008, 1201:167-176.
29. Gohil K., Vasu V.T., Cross C.E. Dietary alpha-tocopherol and neuromuscular health: search for optimal dose and molecular mechanisms continues!. Mol Nutr Food Res 2010, 54:693-709.
30. Goss-Sampson M.A., MacEvilly C.J., Muller D.P. Longitudinal studies of the neurobiology of vitamin E and other antioxidant systems, and neurological function in the vitamin E deficient rat. J Neurol Sci 1988, 87:25-35.
31. Goss-Sampson M.A., Kriss A., Muller D.P. A longitudinal study of somatosensory, brainstem auditory and peripheral sensory-motor conduction during vitamin E deficiency in the rat. J Neurol Sci 1990, 100:79-84.
32. Greco S.J., Bryan K.J., Sarkar S., Zhu X., Smith M.A., Ashford J.W., Johnston J.M., Tezapsidis N., Casadesus G. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 2010, 19:1155-1167.
33. Harding A.E. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. Brain 1982, 105:1-28.
34. Harding A.E., Matthews S., Jones S., Ellis C.J., Booth I.W., Muller D.P. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med 1985, 313:32-35.
35. Harding A.E. Vitamin E and the nervous system. Crit Rev Neurobiol 1987, 3:89-103.
36. Hart P.E., Lodi R., Rajagopalan B., Bradley J.L., Crilley J.G., Turner C., Blamire A.M., Manners D., Styles P., Schapira A.H., Cooper J.M. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 2005, 62:621-626.
37. Hensley K., Barnes L.L., Christov A., Tangney C., Honer W.G., Schneider J.A., Bennett D.A., Morris M.C. Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance. J Alzheimers Dis 2011, 24:767-774.
38. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., Arai H., Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997, 409:105-108.
39. Hyland S., Muller D., Hayton S., Stoecklin E., Barella L. Cortical gene expression in the vitamin E-deficient rat: possible mechanisms for the electrophysiological abnormalities of visual and neural function. Ann Nutr Metab 2006, 50:433-441.
40. Jishage K., Arita M., Igarashi K., Iwata T., Watanabe M., Ogawa M., Ueda O., Kamada N., Inoue K., Arai H., Suzuki H. Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J Biol Chem 2001, 276:1669-1672.
41. Jones B.J., Roberts D.J. The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 1968, 20:302-304.
42. Kern J.K., Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006, 9:485-499.
43. Ko D.C., Milenkovic L., Beier S.M., Manuel H., Buchanan J., Scott M.P. Cell-autonomous death of cerebellar Purkinje neurons with autophagy in Niemann-Pick type C disease. PLoS Genet 2005, 1:81-95.
44. Koeppen A.H. The pathogenesis of spinocerebellar ataxia. Cerebellum 2005, 4:62-73.
45. Koeppen A.H. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 2011, 303:1-12.
46. Liu Q., Xie F., Rolston R., Moreira P.I., Nunomura A., Zhu X., Smith M.A., Perry G. Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Rev Med Chem 2007, 7:171-180.
47. Matsuya M., Matsumoto H., Chiba S., Kashiwagi M., Kasahara M. A sporadic case of essential vitamin E deficiency manifested by sensory-dominant polyneuropathy and retinitis pigmentosa. No To Shinkei 1994, 46:989-994.
48. Mayhew I.G., Brown C.M., Stowe H.D., Trapp A.L., Derksen F.J., Clement S.F. Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial. J Vet Int Med 1987, 1:45-50.
49. Muller D.P. Vitamin E and neurological function. Mol Nutr Food Res 2010, 54:710-718.
50. Nishida Y., Yokota T., Takahashi T., Uchihara T., Jishage K., Mizusawa H. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 2006, 350:530-536.
51. Nishida Y., Ito S., Ohtsuki S., Yamamoto N., Takahashi T., Iwata N., Jishage K., Yamada H., Sasaguri H., Yokota S., Piao W., Tomimitsu H., Saido T.C., Yanagisawa K., Terasaki T., Mizusawa H., Yokota T. Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J Biol Chem 2009, 284:33400-33408.
52. O'Byrne D., Grundy S., Packer L., Devaraj S., Baldenius K., Hoppe P.P., Kraemer K., Jialal I., Traber M.G. Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 2000, 29:834-845.
53. Optican L.M. Low rates yield big returns. Nat Neurosci 1998, 1:8-9.
54. Ouahchi K., Arita M., Kayden H., Hentati F., Ben Hamida M., Sokol R., Arai H., Inoue K., Mandel J.L., Koenig M. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995, 9:141-145.
55. Pandolfo M. Friedreich ataxia. Arch Neurol 2008, 65:1296-1303.
56. Paula-Barbosa M.M., Ruela C., Tavares M.A., Pontes C., Saraiva A., Cruz C. Cerebellar cortex ultrastructure in ataxia-telangiectasia. Ann Neurol 1983, 13:297-302.
57. Perrone S., Longini M., Bellieni C.V., Centini G., Kenanidis A., De Marco L., Petraglia F., Buonocore G. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007, 40:177-180.
58. Pillai S.R., Traber M.G., Kayden H.J., Cox N.R., Toivio-Kinnucan M., Wright J.C., Braund K.G., Whitley R.D., Gilger B.C., Steiss J.E. Concomitant brainstem axonal dystrophy and necrotizing myopathy in vitamin E-deficient rats. J Neurol Sci 1994, 123:64-73.
59. Podratz J.L., Rodriguez E.H., Windebank A.J. Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro. Glia 2004, 45:54-58.
60. Ren Y.R., Nishida Y., Yoshimi K., Yasuda T., Jishage K., Uchihara T., Yokota T., Mizuno Y., Mochizuki H. Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain. J Neurochem 2006, 98:1810-1816.
61. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997, 336:1216-1222.
62. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 1953, 87:387-406.
63. Simon D., Seznec H., Gansmuller A., Carelle N., Weber P., Metzger D., Rustin P., Koenig M., Puccio H. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J Neurosci 2004, 24:1987-1995.
64. Sokol R.J. Vitamin E deficiency and neurologic disease. Annu Rev Nutr 1988, 8:351-373.
65. Sokol R.J. Vitamin E and neurologic deficits. Adv Pediatr 1990, 37:119-148.
66. Sontag T.J., Parker R.S. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 2002, 277:25290-25296.
67. Sontag T.J., Parker R.S. Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase. J Lipid Res 2007, 48:1090-1098.
68. Southam E., Thomas P.K., King R.H., Goss-Sampson M.A., Muller D.P. Experimental vitamin E deficiency in rats. Morphological and functional evidence of abnormal axonal transport secondary to free radical damage. Brain 1991, 114(Pt 2):915-936.
69. Sultana R., Butterfield D.A. Slot-blot analysis of 3-nitrotyrosine-modified brain proteins. Methods Enzymol 2008, 440:309-316.
70. Sung J.H., Mastri A.R., Park S.H. Axonal dystrophy in the gracile nucleus in children and young adults. Reappraisal of the incidence and associated diseases. J Neuropathol Exp Neurol 1981, 40:37-45.
71. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., Pratico D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J 2004, 18:323-325.
72. Terasawa Y., Ladha Z., Leonard S.W., Morrow J.D., Newland D., Sanan D., Packer L., Traber M.G., Farese R.V. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E. Proc Natl Acad Sci U S A 2000, 97:13830-13834.
73. Thomas P.K., Cooper J.M., King R.H., Workman J.M., Schapira A.H., Goss-Sampson M.A., Muller D.P. Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function. J Anat 1993, 183(Pt 3):451-461.
74. Traber M.G., Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007, 43:4-15.
75. Ulatowski L., Dreussi C., Noy N., Barnholtz-Sloan J., Klein E., Manor D. Expression of the alpha-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms. Free Radic Biol Med 2012, 53:2318-2326.
76. Vatassery G.T., Lam C., Smith W.E., Quach H.T. Apolipoprotein E exerts selective and differential control over vitamin E concentrations in different areas of mammalian brain. J Neurosci Res 2006, 84:1335-1342.
77. Vatassery G.T., Quach H.T., Smith W.E., Santacruz K.S., Roy S. Apolipoprotein e deficiency leads to altered brain uptake of alpha tocopherol injected into lateral cerebral ventricles. Biochim Biophys Acta 2007, 1772:797-803.
78. Womack M.D., Khodakhah K. Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons. J Neurosci 2003, 23:2600-2607.
79. Wright M.E., Peters U., Gunter M.J., Moore S.C., Lawson K.A., Yeager M., Weinstein S.J., Snyder K., Virtamo J., Albanes D. Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Res 2009, 69:1429-1438.
80. Yokota T., Shiojiri T., Gotoda T., Arai H. Retinitis pigmentosa and ataxia caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med 1996, 335:1770-1771.
81. Yokota T., Uchihara T., Kumagai J., Shiojiri T., Pang J.J., Arita M., Arai H., Hayashi M., Kiyosawa M., Okeda R., Mizusawa H. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 2000, 68:521-525.
82. Yokota T., Igarashi K., Uchihara T., Jishage K., Tomita H., Inaba A., Li Y., Arita M., Suzuki H., Mizusawa H., Arai H. Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci U S A 2001, 98:15185-15190.
83. Yoshida Y., Itoh N., Hayakawa M., Habuchi Y., Saito Y., Tsukamoto Y., Cynshi O., Jishage K., Arai H., Niki E. The role of alpha-tocopherol in motor hypofunction with aging in alpha-tocopherol transfer protein knockout mice as assessed by oxidative stress biomarkers. J Nutr Biochem 2010, 21:66-76.
84. Yu T., Lieberman A.P. Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin. PLoS Genet 2013, 9:e1003462.